Fitoterapia de la litiasis renal: Entre el mito y la realidad

Medicina Clinica

Volumn 115, Issue 20, 2000, Pages 779-782

  Grases, F ^a   Costa Bauza A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Phytotherapy; Renal calculi; Renal lithiasis; Saponins

Indexed keywords

ARTICLE; HISTORY; HUMAN; MEDICAL LITERATURE; MEDICINAL PLANT; NEPHROLITHIASIS; PHYTOTHERAPY;

HISTORY, 16TH CENTURY; HUMANS; KIDNEY CALCULI; PHARMACOPOEIAS; PHYTOTHERAPY; PLANTS, MEDICINAL;

EID: 0034627413     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71690-3     Document Type: Article

References (19)

1. a ed.). Barcelona: Labor, 1983.
2. Fernández M. Nieto A. Plantas medicinales. Pamplona: Ed. Universidad de Navarra, 1982.
3. a ed.), Barcelona; Susaeta, 1989.
4. Fernández-Pola J. Plantas medicinales. Un recetario básico. Barcelona: Omega, 1987.
5. Hantinuais. Sabal serrulata. Travaux de la Societé de Montpelier, 1981; 41: 253.
6. Nieto A. Plantas medicinales con acción diurética. Panorama, actual del medicamento 1985; 80: 24.
7. Nieto A. Plantas medicinales activas a nivel urinario. Panorama actual del medicamento 1986; 99: 375-376.
8. Grases F, Masárová L, Costa-Bauzá A, March JG, Prieto RM, Tur JA. Eflect of Rosa canina infusion and magnesium on the urinary risk factors of calcium oxalate urolithiasis. Plant Med 1992; 58: 509-512.
9. Grases F, March JG, Ramis M, Costa-Bauzá A. The influence of Zea mays on urinary risk factors for kidney stones in rats. Phytotherapy Res 1993; 7: 146-149.
10. Grases F, Melero G, Costa-Bauzá A, Prieto R, March JG. Urolithiasis and Phytotherapy. Int Urol Nephrol 1994; 26: 507-511.
11. Grases F, Ramis M, Costa-Bauzá A, March JG. Effect of Herniaria hirsuta and Agropyron repnes on calcium oxalate urolithiasis risk in rats. J Ethnopharmacology 1995; 45: 211-214.
12. a ed.). París: Commision Nationale de Pharmacopeé, 1982.
13. Fouraste I, Francois I. Sur quelques Ericacée medicinaux. XVII Congreso Internacional del Mediterranée Latino. Alicante, 1986.
14. Nieto A. Arctostaphyllus uva ursi. Panorama actual del medicamento 1983; 65: 34-35.
15. Bezanger-Beauquense. Revisones de fitoterapia. PI Med Phyt 1988; 1: 40.
16. Grases F, García-Ferragut L, Costa-Bauzá A, March JG. Study of the effects of different substances on the early stages of papillary stone formation. Nephron 1996; 73: 561-568.
17. Grases F, Ramis M, Villacampa AI, Costa-Bauzá A. Uric acid urolithiasis and crystallization inhibitions. Urol Int 1999; 62: 201-204.
18. Grases F, Costa-Bauzá A, Garcia-Gonzalez R, Payeras A, Bassa A, Torres JJ et al. Indinavir crystallization and urolithiasis. Int Urol Nephrol 1999; 31: 23-39.
19. Grases F, García R, Redondo E, Costa-Bauzá A, Simonet BM, Sartini RP et al. A pilot clinical trial to evaluate the safety and efficacy of a saponin (escin) as inhibitor of the indinavir (IDV) crystallization in urine of HIV-infected patients. 40 Interscience Conference on Antimicrobial Agents and Chenotherapy, Toronto, 2000.